Please login to the form below

Not currently logged in
Email:
Password:

factor X concentrate

This page shows the latest factor X concentrate news and features for those working in and with pharma, biotech and healthcare.

CHMP backs orphan drugs Uptravi and Coagadex

CHMP backs orphan drugs Uptravi and Coagadex

The panel backed Coagudex (factor X concentrate) from Bio Products Laboratory for the treatment of factor X deficiency, a rare inherited bleeding disorder, along with Actelion's Uptravi (selexipag) for pulmonary ... deficiency. The product works as

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics